Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34) | RFA MH 17 612

Opportunity Information: Apply for RFA MH 17 612

Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34) is a National Institutes of Health grant opportunity from the National Institute of Mental Health (NIMH) designed to fund early, pilot-stage studies that help bridge the gap between an intervention that has shown efficacy under controlled conditions and its real-world use in typical community or service settings. The FOA (RFA-MH-17-612; CFDA 93.242) focuses on building the kind of practical evidence needed before launching a much larger and more expensive effectiveness trial or services study. In plain terms, it supports the "prove it can work out there" and "show we can run the study" phase, rather than a full-scale definitive trial.

The opportunity has two main lanes. First, it supports effectiveness research on preventive or therapeutic interventions that already have evidence of efficacy, but now need to be tested in broader, more diverse populations or in routine practice environments such as community clinics, schools, primary care, or other non-research settings. This includes situations where an intervention works in a tightly controlled academic trial, but you still need to learn whether it remains beneficial when delivered by typical providers, to people with more complex comorbidities, and under the time, staffing, and resource constraints that real systems face. Second, it supports development and preliminary testing of innovative services interventions, meaning strategies aimed at improving how mental health services are organized, delivered, accessed, coordinated, or sustained. These could include new care models, service delivery workflows, implementation supports, navigation approaches, or system-level changes that are intended to improve clinical and functional outcomes by improving the service environment itself.

A central expectation is that applications propose a pilot study that generates key preliminary evidence on whether a larger trial is justified and feasible. The FOA specifically highlights feasibility, tolerability, acceptability, and safety as core targets for evaluation. Feasibility typically refers to whether the intervention and the research procedures can actually be carried out in the intended setting (for example, whether recruitment works, whether providers can deliver the program with available training, whether follow-up data collection is realistic, and whether the intervention fits the setting’s workflow). Acceptability and tolerability address whether participants, providers, and stakeholders are willing to engage with the intervention and whether the burden, time demands, and perceived value make participation realistic. Safety involves monitoring adverse events and other potential harms, which is especially important when moving into broader, less-controlled environments. Alongside these outcomes, projects are expected to collect preliminary data relevant to mental health or functional outcomes, relevant risk factors, or service delivery metrics, with the explicit purpose of preparing for a later larger-scale intervention trial such as a comparative effectiveness study, a practical trial, or a large services study.

Because this is an R34 mechanism, it is generally oriented toward pilot effectiveness trials rather than basic discovery work or fully powered confirmatory clinical trials. The intent is to fund work that is rigorous enough to meaningfully inform a next-step study design (including estimates of recruitment, retention, adherence, outcome variability, and signal of benefit), but still scoped as an initial, preparatory trial. Competitive applications typically make a clear case that the intervention is ready for effectiveness-oriented piloting (for treatment or prevention interventions, prior efficacy evidence is expected), that the setting and target population are appropriate to NIMH priorities, and that the study will directly inform a subsequent larger application with a credible pathway to scale.

The FOA is broadly open in terms of who can apply. Eligible applicants include many types of U.S. government entities (state, county, city or township, special district governments), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, and Native American tribal governments (federally recognized) as well as tribal organizations that are not federally recognized. It also allows public housing authorities/Indian housing authorities, nonprofit organizations (both with and without 501(c)(3) status), for-profit organizations (other than small businesses), and small businesses, among others. In addition, the announcement explicitly calls out a wide range of other eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; U.S. territories or possessions; and even non-U.S. entities (foreign organizations). This breadth signals NIMH’s interest in piloting interventions in the kinds of real-world contexts where mental health services and preventive programs are actually delivered, including settings serving historically underserved and diverse populations.

Administratively, this is a discretionary NIH grant in the health category. The source data lists an award ceiling of $225,000 (as presented in the record), with an original closing date of December 18, 2017, and a creation date of December 13, 2016. While those dates indicate this specific posting is historical, the summary still reflects the core purpose and structure of the opportunity: to support carefully designed pilot studies that test whether evidence-based preventive or therapeutic interventions translate effectively into broader practice, and to develop and preliminarily test innovative services interventions that could improve mental health outcomes by improving service delivery.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
• This funding opportunity was created on 2016-12-13.
• Applicants must submit their applications by 2017-12-18. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $225,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA MH 17 612

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: